Nuclear Medicine & Radiopharmaceuticals Market to Witness Huge Growth by 2030 – Actinium Pharmaceuticals Inc., Alliance Medical, Avid Bioservices Inc

Nuclear Medicine or Radiopharmaceuticals Market Size Was Valued at USD 6.13 Billion in 2022, and is Projected to Reach USD 11.0 Billion by 2030, Growing at a CAGR of 7.6% From 2023-2030.

Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged-for example, positronemitting radiopharmaceuticals.

Top Key Players Covered in The Global Nuclear Medicine or Radiopharmaceuticals Market

Actinium Pharmaceuticals Inc. (U.S.), Alliance Medical (U.K.), Avid Bioservices Inc(U.S.), Bayer Healthcare Pharmaceuticals (Germany), Bracco Diagnostics Inc. (Italy), Cardinal Health Inc. (U.S.), Ge Healthcare (U.S.), Ion Beam Applications S.A (Belgium), Jubilant Pharma (India), Lantheus Medical Imaging Inc. (U.S.), Medi-Radiopharma Ltd (Hungary), Nordion Inc. (Canada), Novartis/Advanced Accelerator Applications (France), Positron Corporation (U.S.), Radiopharm Theranostics Ltd. (U.S.), Curium (France), Eli Lilly And Company (U.S.), Fujifilm Toyama Chemical Co., Ltd. (Japan), Nihon Medi-Physics. Co. Ltd. (Japan), Samyoung Unitech (South Korea), Duchembio, Inc. (South Korea) and Other Major Players

Sample Report Available at Zero Cost!

https://introspectivemarketresearch.com/request/15924

Introspective Market Research is a globally trusted Market Research partner delivering comprehensive market research studies that provide businesses with invaluable insights and strategic guidance for informed decision-making. Our studies are based on extensive array of primary and secondary sources and ensures the utmost accuracy and reliability in our findings.

At the core of our study is an in-depth analysis of the Nuclear Medicine or Radiopharmaceuticals Market ecosystem, where we thoroughly examine the functions and interdependencies of various market stakeholders. Through our expert utilization of trusted methodologies, including SWOT Analysis, Porter’s Five Forces Analysis, and Price Trend Analysis, we offer a comprehensive understanding of both the regulatory landscape and the prevailing trends shaping the industry.

Segmentation:

By Product Type       

  • Diagnostic
  • Therapeutic

By Modality   

  • Single-Photon Emission Computed Tomography (SPECT)
  • Positron Emission Tomography (PET)
  • Alpha Emitters
  • Beta Emitters
  • Brachytherapy

By Application          

  • Oncology
  • Cardiology
  • Neurology

By End User   

  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers

Key Industry Developments In Nuclear Medicine or Radiopharmaceuticals Market

Technological Advancements:

Theranostics: This involves using molecular imaging to tailor personalized therapy. It’s gaining traction as a promising approach for cancer treatment.

PET-CT and SPECT-CT: Advances in hybrid imaging technologies have improved diagnostic accuracy, especially in oncology and neurology.

New Radiopharmaceuticals:

PSMA-targeted radiopharmaceuticals: Used in prostate cancer imaging and therapy, these agents are becoming more widely available.

DOTA-conjugated peptides: Used in neuroendocrine tumor imaging and treatment, these represent a growing class of radiopharmaceuticals.

Tailor-Made Reports – Your Insights, Your Way!

https://introspectivemarketresearch.com/custom-research/15924

By Region

  • North America (US, Canada, Mexico)
  • Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Make Your Move – Secure Your Purchase!

https://introspectivemarketresearch.com/checkout/?user=1&_sid=15924

About us:

Introspective Market Research (introspectivemarketresearch.com) is a visionary research consulting firm dedicated to assist our clients grow and have a successful impact on the market. Our team at IMR is ready to assist our clients flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, specialized in using big data and advanced analytics to show the bigger picture of the market trends.

We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.

Contact us:

Introspective Market Research

3001 S King Drive,

Chicago, Illinois

60616 USA

Ph no: +1 773 382 1049

Email: sales@introspectivemarketresearch.com

LinkedIn | Twitter | Facebook